MapLight Therapeutics may offer up to $400 million of securities
MPLT•MapLight Therapeutics said in an SEC filing that it may offer up to $400 million of securities, including up to $100 million of common stock under a sales agreement.
MPLT•MapLight Therapeutics said in an SEC filing that it may offer up to $400 million of securities, including up to $100 million of common stock under a sales agreement.
MapLight Therapeutics said in an SEC filing that it may offer up to $400 million of securities. It may offer up to $100 million of common stock under a sales agreement.